The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
C3 Glomerulonephritis Associated With Monoclonal Gammopathy: A Case Series
Open accessAbstract
Background C3 Glomerulonephritis (C3GN) is a proliferative glomerulonephritis resulting from glomerular deposition of complement factors due to dysregulation of the alternative pathway of complement. The dysregulation of the alternative pathway of complement may occur as a result of mutations or functional inhibition of complement regulating proteins. Functional inhibition of the complement regulating proteins may result from a monoclonal gammopathy. Study Design Case series Setting and Participants 32 Mayo Clinic patients of C3GN, of which 10 patients (31.25%) had evidence of a monoclonal immunoglobulin in the serum. Outcomes Clinical features, hematological and bone marrow biopsy findings, kidney biopsy findings, renal outcomes, complement pathway abnormalities, treatment and follow-up of patients with C3GN that was associated with a monoclonal gammopathy. Results The mean age of patients with C3GN associated with monoclonal gammopathy was 54.5 years. Bone marrow biopsy done in 9 patients revealed monoclonal gammopathy of undetermined significance (MGUS) in 5 patients, small lymphocytic lymphoma/chronic lymphocytic leukemia (CLL) in one patient ,and no abnormal clones in the remaining 3 patients. Kidney biopsy showed a membranoproliferative glomerulonephritis with bright capillary wall C3 staining in all 10 patients. Evaluation of the alternative pathway of complement showed abnormalities in 7 of the 9 patients tested. None of the patients had a mutation in the complement regulating proteins. As an index case, one patient with C3GN and CLL was treated with Rituximab, cyclophosphamide, vincristine and prednisone and one patient with C3GN and MGUS was treated with dexamethasone and bortezomib. Both patients showed significant decrease in hematuria and proteinuria, and stabilization of renal function. Limitations Studies to show evidence of direct activation of the alternative pathway by the monoclonal immunoglobulin were not done. Conclusions The study highlights the association of C3GN and monoclonal gammopathy, in particular in the older population, and the importance of targeting the underlying hematologic malignancy as an approach to treating C3GN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of monoclonal gammopathy of undetermined significance
Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Larson, D. R., Plevak, M. F., Offord, J. R., Dispenzieri, A., Katzmann, J. A., & Melton, L. J. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054494 · Cited by 1,423
Cited by
Leung, N., Bridoux, F., Batuman, V., Chaidos, A., Cockwell, P., D’Agati, V. D., Dispenzieri, A., Fervenza, F. C., Fermand, J.-P., Gibbs, S., et al. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0077-4 · Cited by 551
Self-citationDiagnosis of monoclonal gammopathy of renal significance
Bridoux, F., on behalf of the International Kidney and Monoclonal Gammopathy Research Group, Leung, N., Hutchison, C. A., Touchard, G., Sethi, S., Fermand, J.-P., Picken, M. M., Herrera, G. A., Kastritis, E., et al. (2015) · Kidney International · doi:10.1038/ki.2014.408 · Cited by 426
Self-citationDiseases of complement dysregulation-an overview
Wong, E. K. S., & Kavanagh, D. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-017-0663-8 · Cited by 115
Metadata
- Authors
- Zand, L., Kattah, A., Fervenza, F. C., Smith, R. J. H., Nasr, S. H., Zhang, Y., Vrana, J. A., Leung, N., Cornell, L. D., & Sethi, S.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 62
- Issue
- 3
- Pages
- 506-514
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2093780976
- Cited by
- 182
- References
- 1
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: C3 Glomerulonephritis Associated With Monoclonal Gammopathy: A Case Series. https://app.cochat.ai/papers/10.1053/j.ajkd.2013.02.370
- The paper
- Zand, L., Kattah, A., Fervenza, F. C., Smith, R. J. H., Nasr, S. H., Zhang, Y., Vrana, J. A., Leung, N., Cornell, L. D., & Sethi, S. (2013). C3 Glomerulonephritis Associated With Monoclonal Gammopathy: A Case Series. American Journal of Kidney Diseases. https://doi.org/10.1053/j.ajkd.2013.02.370
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.